BioSpace News Archive

Wilmington, Delaware, United States: The global oral care products market is anticipated to witness moderate growth during the forecast period between 2021 and 2031.

In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels.

Kineta, Inc. announced that it presented the Phase 1/2 clinical trial design and new preclinical data supporting KVA12.1 as a potential treatment for cancer patients with advanced solid tumors at the Tumor Myeloid-Directed Therapies Summit held on June 14-16 in Boston, MA.

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting (AGM) of Shareholders held on Thursday, June 16, 2022.

June 17, 2022 11:00 UTC Company advancing ZB-168, an anti-IL7R α monoclonal antibody, originally developed by Pfizer Inc., in multiple phase 2 clinical trials The transaction values the combined companies at a pro forma enterprise value of $215 million Total gross proceeds of up to $189 million of which up to $139 million is from the cash held in trust (assuming no redemptions) and $50 million from the committed forward purchase agreement and PIPE investments

Cyclerion Therapeutics, Inc. today announced research from preclinical studies demonstrating treatment with its lead soluble guanylate cyclase (sGC) stimulator, CY6463, was associated with improved cellular energetics and reduced inflammation in preclinical models of mitochondrial disease.

Oral Presentation at FSHD IRC highlights preclinical data that demonstrated prevention of muscle weakness by reducing DUX4 expression.

Last night bit.bio won the Emerging Star prize at the European Mediscience Awards in a ceremony at the Hotel InterContinental in London.

The latest market analysis report published by Reports and Data, titled ‘Global Acute Repetitive Seizures Market – Forecast to 2028,’ thoroughly examines the Acute Repetitive Seizures industry to provide essential data & information for the targeted readers.

The global generic injectables market size was significantly robust in 2020 and is expected to register a steady revenue CAGR over the forecast period.